rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

Biohaven Ltd. Common Shares

BHVN · NYSE

Health CareBiotechnologySetting up

BHVN stood above a rising 150-day average in 13 of the last 52 weekly readings, and has been out of that trend for the last 3 weeks. It is 4.7% below that average now. Biotechnology: 18% of its 561 stocks in an uptrend (−12 points in four weeks); Health Care: 28% (−6 points in four weeks).

Statistics

Rotation
Setting up
Weeks in an uptrend
out for 3
Industry in uptrend
18% -12 in 4 wk
Insider buys, 12 months
$33.1M
Insider sales, 12 months
$0
Officials’ trades on record
0
Institutions holding
280 (+19)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 13 of 52 weeks.

22 Apr – 21 Oct
16%27%39%Apr 26Jun 26Jul 26Sep 26Oct 26

Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has been slipping.

Money in and out

1 Nov 2024 – 1 Oct 2026
$0$32.0MNov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months4
Sale orders, 12 months0
Buyers · sellers4 · 0
WhoDidSharesTraded
John W. ChildsDirectorbought28,400at $30.434 Mar 2025filed 9 Mar 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders280+19 on the quarter
New · exited50 · 32
Reported value$2.1B

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
BlackRock, Inc.added · filed 7 Aug 202613,210,585$196.6M+1,988,178+17.7%
MONTANOVA CAPITAL, LLCunchanged · filed 14 Aug 202610,286,937$153.1M00.0%
STIFEL FINANCIAL CORPadded · filed 12 Aug 20269,941,165$147.9M+2800.0%
Jupiter Topco LLCnew · filed 14 Aug 20268,584,675$127.9M+8,584,675
Woodline Partners LPadded · filed 14 Aug 20267,660,280$114.0M+7,359,891+2450.1%
STATE STREET CORPadded · filed 7 Aug 20266,947,034$103.4M+328,231+5.0%
INFINITUM ASSET MANAGEMENT, LLCunchanged · filed 14 Aug 20266,250,000$93.0M00.0%
D. E. Shaw & Co., Inc.added · filed 14 Aug 20264,190,195$62.4M+1,343,002+47.2%
AQR CAPITAL MANAGEMENT LLCadded · filed 14 Aug 20264,150,616$61.8M+2,175,100+110.1%
GEODE CAPITAL MANAGEMENT, LLCadded · filed 12 Aug 20263,323,190$49.5M+555,427+20.1%
31 Mar 2023 – 30 Jun 2026
155215275Mar 23Dec 23Dec 24Sep 25Jun 26

Everyone who traded it

Kimberly Gentile Company insiderSVP, Clinical Operations · last 15 Sep 20260 · 0
Gregory Bailey Company insiderDirector · last 28 Apr 20267 · 0
Irina Antonijevic Company insiderDirector · last 28 Apr 20260 · 1
John W. Childs Company insiderDirector · last 28 Apr 202616 · 0
Julia P. Gregory Company insiderDirector · last 28 Apr 20261 · 0
Kishan Mehta Company insiderDirector · last 28 Apr 20260 · 0
Michael Thomas Heffernan Company insiderDirector · last 28 Apr 20260 · 0
Robert J. Hugin Company insiderDirector · last 28 Apr 20260 · 0
Bruce Car Company insiderChief Scientific Officer · last 27 Feb 20261 · 0
George C. Clark Company insiderVP, Chief Accounting Officer · last 27 Feb 20261 · 0
Matthew Buten Company insiderChief Financial Officer · last 27 Feb 20262 · 0
Vlad Coric Company insiderChief Executive Officer · last 27 Feb 20268 · 0

Same industry

MRNA ModernaLeading+168%
ENTX Entera BioLeading+53%
XNCR XencorLeading+41%

Distance from each stock’s own 150-day average.

Government contracts

No federal award is tied to it.

From its SEC filings

Share count trendFY 2025 · to 26 Feb 202613.3%
Cash and equivalentsFY 2025 · to 31 Dec 2025$230.0M
Free cash flowFY 2025 · to 31 Dec 2025−$610.2M

Analyst forecasts

No analyst forecasts yet.